Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang(Pfizer (United States)), Siu Tsan Yuen(Queen Mary Hospital), Jiangchun Xu(Pfizer (United States)), Siu Po Lee(Queen Mary Hospital), Helen H.N. Yan(Queen Mary Hospital), Stephanie T. Shi(Pfizer (United States)), Hoi Cheong Siu(Queen Mary Hospital), Shibing Deng(Pfizer (United States)), Kent‐Man Chu(Queen Mary Hospital), Simon Law(Queen Mary Hospital), Kok Hoe Chan(Queen Mary Hospital), Annie S Y Chan(Queen Mary Hospital), Wai Yin Tsui(Queen Mary Hospital), Siu Lun Ho(Queen Mary Hospital), Anthony K W Chan(Queen Mary Hospital), Jonathan L K Man(Queen Mary Hospital), Valentina Foglizzo(Medical Research Council), Man Kin Ng(Queen Mary Hospital), April Chan(Queen Mary Hospital), Ching C. Lau(University of Hong Kong), Grace H.W. Cheng(Queen Mary Hospital), Tao Xie(Pfizer (United States)), Julio Fernandez-Banet(Pfizer (United States)), Vivian Li(Medical Research Council), Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research), Paul A. Rejto(Pfizer (United States)), Mao Mao(Pfizer (United States)), Suet Yi Leung(Queen Mary Hospital)
Cited by 1,069